something else i like about yr chat with Carl was his upfront can't comment on commercially confidential stuff or to that effect.
when we knew something had to be happening with Tacere following the excellent NHP HCV study paper release, we were getting a flat 'can't comment' with respect to Tacere.
thus the upfront qualification from Carl makes it clear something's up alright. too bad for the forced sale today, hope they can get back in, because this is not a time to sell out of benitec!!!!
BLT Price at posting:
40.0¢ Sentiment: Buy Disclosure: Held